Dilyse Kong

Dilyse Kong is a Management Executive at Tan Tock Seng Hospital, having previously held the position of Management Associate within the same organization since July 2022. Prior to this role, Dilyse was involved in research at the Lee Kong Chian School of Medicine, contributing to the development of an automated high throughput protocol for phage therapy from August 2021 to May 2022. An internship at GSK provided exposure to manufacturing processes, GMP, and CAPA, while experience as a Research Assistant at Nanyang Technological University focused on antimicrobial peptides targeting gram-negative bacteria. Additional internships included a Clinic Research Intern position at Cognifyx, where Dilyse gained insights into neuroscience, and a Clinic Assistant role at Point Medical Group. Dilyse holds a Bachelor of Engineering in Biomedical/Medical Engineering from Nanyang Technological University, completed in 2022.